Fewer postoperative fevers: an unexpected benefit of multimodal pain management?

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3971226)

Published in Clin Orthop Relat Res on May 01, 2014

Authors

Joseph A Karam1, Benjamin Zmistowski, Camilo Restrepo, William J Hozack, Javad Parvizi

Author Affiliations

1: Department of Orthopaedic Surgery, The Rothman Institute at Thomas Jefferson University, The Sheridan Building, 125 S 9th Street, Suite 1000, Philadelphia, PA, 19107, USA.

Articles cited by this

Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA (2003) 1.65

Evaluation of postoperative fever and leukocytosis in patients after total hip and knee arthroplasty. J Arthroplasty (2011) 1.54

Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology (2005) 1.46

Multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am (2011) 1.26

Pain management in total joint arthroplasty: a historical review. Orthopedics (2010) 1.25

Febrile response after knee and hip arthroplasty. Clin Orthop Relat Res (1999) 1.04

Cost and effectiveness of postoperative fever diagnostic evaluation in total joint arthroplasty patients. J Arthroplasty (2010) 1.02

Arthritis progression after patellofemoral joint replacement. Knee (2006) 1.00

Continuous intravenous administration of ketorolac reduces pain and morphine consumption after total hip or knee arthroplasty. Anesth Analg (1995) 0.99

Pyrexia after total knee replacement. A cause for concern? Am J Orthop (Belle Mead NJ) (1997) 0.92

A prospective evaluation of 2 different pain management protocols for total hip arthroplasty. J Arthroplasty (2010) 0.88

Pyrexia following total knee replacement. Knee (2006) 0.87

An intensive perioperative regimen of pregabalin and celecoxib reduces pain and improves physical function scores six weeks after total hip arthroplasty: a prospective randomized controlled trial. Pain Res Manag (2013) 0.86

Oxymorphone and oxymorphone extended release: a pharmacotherapeutic review. J Opioid Manag (2008) 0.85

Elevated temperature trends after total knee arthroplasty. Orthopedics (2009) 0.84

Pain management following total joint arthroplasty: making strides. J Bone Joint Surg Am (2012) 0.83

Evaluation of fever in the immediate postoperative period in patients who underwent total joint arthroplasty. J Arthroplasty (2011) 0.82

Articles by these authors

Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res (2003) 12.86

New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res (2011) 5.59

Insall Award paper. Why are total knee arthroplasties failing today? Clin Orthop Relat Res (2002) 5.19

Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res (2008) 5.05

Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty (2008) 4.11

Economic burden of periprosthetic joint infection in the United States. J Arthroplasty (2012) 4.01

Anterior femoroacetabular impingement: part II. Midterm results of surgical treatment. Clin Orthop Relat Res (2004) 3.93

Anterior femoroacetabular impingement: part I. Techniques of joint preserving surgery. Clin Orthop Relat Res (2004) 3.46

Diagnosis of periprosthetic infection. J Bone Joint Surg Am (2006) 3.04

International consensus on periprosthetic joint infection: description of the consensus process. Clin Orthop Relat Res (2013) 2.93

Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am (2008) 2.74

Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res (2009) 2.45

Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am (2012) 2.43

Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty (2009) 2.40

Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem (2003) 2.25

Operating room traffic is a major concern during total joint arthroplasty. Clin Orthop Relat Res (2012) 2.18

Modular taper junction corrosion and failure: how to approach a recalled total hip arthroplasty implant. J Arthroplasty (2013) 2.13

The direct and indirect costs to society of treatment for end-stage knee osteoarthritis. J Bone Joint Surg Am (2013) 2.12

Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res (2014) 2.11

Custom-fit total knee arthroplasty (OtisKnee) results in malalignment. J Arthroplasty (2008) 2.11

Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am (2008) 2.09

Total joint arthroplasty: When do fatal or near-fatal complications occur? J Bone Joint Surg Am (2007) 2.07

Prospective randomized study of two surgical approaches for total hip arthroplasty. J Arthroplasty (2010) 2.03

Criteria used by medical students to rank orthopedic surgery residency programs. Am J Orthop (Belle Mead NJ) (2006) 2.01

The role of patient restrictions in reducing the prevalence of early dislocation following total hip arthroplasty. A randomized, prospective study. J Bone Joint Surg Am (2005) 1.95

Safety of simultaneous bilateral total knee arthroplasty. A meta-analysis. J Bone Joint Surg Am (2007) 1.89

Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells (2003) 1.82

Definition of periprosthetic joint infection: is there a consensus? Clin Orthop Relat Res (2011) 1.82

Surgical treatment of limb-length discrepancy following total hip arthroplasty. J Bone Joint Surg Am (2003) 1.81

Muscle damage during MIS total hip arthroplasty: Smith-Petersen versus posterior approach. Clin Orthop Relat Res (2006) 1.69

In hospital complications after total joint arthroplasty. J Arthroplasty (2008) 1.69

The value of intraoperative Gram stain in revision total knee arthroplasty. J Bone Joint Surg Am (2009) 1.58

The 2012 Chitranjan Ranawat award: intraarticular analgesia after TKA reduces pain: a randomized, double-blinded, placebo-controlled, prospective study. Clin Orthop Relat Res (2013) 1.58

American Academy of Orthopaedic Surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee. J Bone Joint Surg Am (2011) 1.57

Total hip arthroplasties: what are the reasons for revision? Int Orthop (2007) 1.55

Ninety-day mortality after bilateral hip arthroplasty. J Arthroplasty (2006) 1.54

The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res (2011) 1.54

The noisy ceramic hip: is component malpositioning the cause? J Arthroplasty (2008) 1.53

The natural progression of synovial fluid white blood-cell counts and the percentage of polymorphonuclear cells after primary total knee arthroplasty: a multicenter study. J Bone Joint Surg Am (2013) 1.53

Failure following revision total knee arthroplasty: infection is the major cause. Int Orthop (2010) 1.53

Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res (2010) 1.50

Diagnosis of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg (2010) 1.50

Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure. Clin Orthop Relat Res (2011) 1.48

Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. J Arthroplasty (2010) 1.47

Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res (2012) 1.46

Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty (2007) 1.45

The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty (2009) 1.44

Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis. J Bone Joint Surg Am (2017) 1.44

Do ceramic femoral heads reduce taper fretting corrosion in hip arthroplasty? A retrieval study. Clin Orthop Relat Res (2013) 1.44

In vivo degradation of polyethylene liners after gamma sterilization in air. J Bone Joint Surg Am (2005) 1.43

The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip. Clin Orthop Relat Res (2015) 1.42

A simple, cost-effective screening protocol to rule out periprosthetic infection. J Arthroplasty (2008) 1.38

Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am (2009) 1.38

Primary total hip arthroplasty with an uncemented femoral component: a long-term study of the Taperloc stem. J Arthroplasty (2004) 1.38

Molecular markers for diagnosis of periprosthetic joint infection. J Arthroplasty (2011) 1.37

Squeaking hips. J Bone Joint Surg Am (2008) 1.36

Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res (2007) 1.35

Demographic factors affecting long-term outcome of total hip arthroplasty. Clin Orthop Relat Res (2003) 1.35

The Chitranjan Ranawat Award: fate of two-stage reimplantation after failed irrigation and débridement for periprosthetic knee infection. Clin Orthop Relat Res (2011) 1.35

The use of a constrained acetabular component to treat instability after total hip arthroplasty. J Bone Joint Surg Am (2003) 1.34

The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis (2009) 1.34

Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res (2009) 1.34

American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am (2009) 1.34

Successful identification of pathogens by polymerase chain reaction (PCR)-based electron spray ionization time-of-flight mass spectrometry (ESI-TOF-MS) in culture-negative periprosthetic joint infection. J Bone Joint Surg Am (2012) 1.34

Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors. J Bone Joint Surg Am (2013) 1.32

Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome? Clin Orthop Relat Res (2010) 1.28

Infection control rate of irrigation and débridement for periprosthetic joint infection. Clin Orthop Relat Res (2011) 1.26

Mark B. Coventry Award: synovial C-reactive protein: a prospective evaluation of a molecular marker for periprosthetic knee joint infection. Clin Orthop Relat Res (2012) 1.25

Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg (2009) 1.25

Frank Stinchfield Award. Titanium surface with biologic activity against infection. Clin Orthop Relat Res (2004) 1.25

Impact of socioeconomic factors on outcome of total knee arthroplasty. Clin Orthop Relat Res (2014) 1.24

The effect of stem design on the prevalence of squeaking following ceramic-on-ceramic bearing total hip arthroplasty. J Bone Joint Surg Am (2010) 1.24

Diagnosis of periprosthetic joint infection. J Arthroplasty (2013) 1.24

The Chitranjan Ranawat Award: Should prophylactic antibiotics be withheld before revision surgery to obtain appropriate cultures? Clin Orthop Relat Res (2014) 1.23

Early mortality after modern total hip arthroplasty. Clin Orthop Relat Res (2008) 1.23

2006 Otto Aufranc Award Paper: significance of in vivo degradation for polyethylene in total hip arthroplasty. Clin Orthop Relat Res (2006) 1.23

Prosthetic joint infection caused by gram-negative organisms. J Arthroplasty (2011) 1.22

The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials (2008) 1.21

Periprosthetic infection: where do we stand with regard to Gram stain? Acta Orthop (2009) 1.21

Complications associated with reimplantation after girdlestone arthroplasty. Clin Orthop Relat Res (2003) 1.21

Perioperative antibiotics should not be withheld in proven cases of periprosthetic infection. Clin Orthop Relat Res (2007) 1.21

Rotating hinged total knee replacement: use with caution. J Bone Joint Surg Am (2007) 1.19

Renal impairment following total joint arthroplasty: who is at risk? J Arthroplasty (2010) 1.18

Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res (2007) 1.18

Recurrent periprosthetic joint infection: persistent or new infection? J Arthroplasty (2013) 1.17